Implementation of the Inflation Reduction Act: Healthcare Reform and Implications for the Pharmaceutical Industry

Nancy Taylor, Co-Chair of the Health Care & FDA practice,  will speak on a live webinar hosted by the FDLI titled "Implementation of the Inflation Reduction Act: Healthcare Reform and Implications for the Pharmaceutical Industry". This session will explore the multi-faceted implications of the IRA on industry and the state of public health, as well as benefits and risks posed by implementing this framework, including impacts on prescription drug affordability, generic drugs, orphan drug exclusivity, differential treatment between small molecules and biologics, and strategy shifting for industry.